![]() |
|
|
Vol. 10, Issue 4, 907-919, April 1999


*Hanson Centre for Cancer Research, Adelaide, South Australia 5000, Australia; and
Max-Planck-Institut für
physiologische und klinische Forshung, W. G. Kerckhoff Institut,
Abteilung Molekulare Zellbiologie, 61231 Bad Nauheim, Germany
| |
ABSTRACT |
|---|
|
|
|---|
Vascular endothelial growth factor (VEGF) is a key regulator of developmental, physiological, and tumor angiogenesis. Upregulation of VEGF expression by hypoxia appears to be a critical step in the neovascularization of solid cancers. The VEGF mRNA is intrinsically labile, but in response to hypoxia the mRNA is stabilized. We have systematically analyzed the regions in the VEGF mRNA that are responsible for its lability under normoxic conditions and for stabilization in response to hypoxia. We find that the VEGF mRNA not only contains destabilizing elements in its 3' untranslated region (3'UTR), but also contains destabilizing elements in the 5'UTR and coding region. Each region can independently promote mRNA degradation, and together they act additively to effect rapid degradation under normoxic conditions. Stabilization of the mRNA in response to hypoxia is completely dependent on the cooperation of elements in each of the 5'UTR, coding region, and 3'UTR. Combinations of any of two of these three regions were completely ineffective in responding to hypoxia, whereas combining all three regions allowed recapitulation of the hypoxic stabilization seen with the endogenous VEGF mRNA. We conclude that multiple regions in the VEGF mRNA cooperate both to ensure the rapid degradation of the mRNA under normoxic conditions and to allow stabilization of the mRNA in response to hypoxia. Our findings highlight the complexity of VEGF gene expression and also reveal a mechanism of gene regulation that could become the target for strategies of therapeutic intervention.
| |
INTRODUCTION |
|---|
|
|
|---|
All tissue growth requires the establishment of an adequate
vascular structure. In its absence the tissue becomes deprived of
oxygen and nutrients and in response the cells produce angiogenic factors, which function to recruit new blood vessels into the undervascularized tissue (Folkman and Shing, 1992
; Battegay, 1995
). Of
the angiogenic factors identified to date, vascular endothelial growth
factor (VEGF) is likely to be a key regulator of angiogenesis (Shweiki
et al., 1992
; Kim et al., 1993
; Millauer et
al., 1994
). VEGF is a secreted, endothelial cell-specific mitogen
that is highly expressed in solid tumors and in areas of active
vascularization (Leung et al., 1989
; Plate et
al., 1992
; Shweiki et al., 1992
). Upregulation of
VEGF expression by hypoxia appears to be a critical step in the process
of neovascularization of solid cancers (Shweiki et al.,
1992
; Kim et al., 1993
; Shweiki et al., 1995
).
Inhibition of VEGF activity in vivo can block both tumor establishment
and progression, by inhibiting vascularization (Kim et al.,
1993
; Millauer et al., 1994
), and VEGF also appears to be
required for the maintenance of tumor blood vessels, because withdrawal
of VEGF leads to breakdown of the vascular structure and consequently tumor regression (Benjamin and Keshet, 1997
).
The upregulation of VEGF expression by hypoxia is due to both
transcriptional activation and a marked stabilization of the normally
labile VEGF mRNA (Ikeda et al., 1995
; Levy et
al., 1995
, 1996a
,b
; Shima et al., 1995
; Stein
et al., 1995
; Damert et al., 1997
).
Transcriptional activation of VEGF is mediated in large part by the
binding of hypoxia inducible factor-1 to an enhancer element in the
5'-flanking region of the VEGF gene (Ikeda et al., 1995
;
Levy et al., 1995
; Forsythe et al., 1996
);
however, relatively little is known about the mechanism of
stabilization of the VEGF mRNA in response to hypoxia. Previous studies
on the regulation of VEGF mRNA stability have focused on the role of
the 3'UTR, which is 1.9 kb in length and contains a number of elements
likely to be important in regulating the stability of the mRNA,
including several copies of the nonameric consensus for the
AU-destabilizing element (Levy et al., 1995
, 1996a
,b
,
1997
; Claffey et al., 1998
). Consistent with the presence of
destabilizing elements, the VEGF 3'UTR can reduce the expression of a
reporter mRNA in vivo (Shima et al., 1996
). In vitro
degradation studies have shown that the VEGF 3'UTR is stabilized in
response to hypoxia (Levy et al., 1996a
,b
), and a number of
studies have demonstrated the presence of binding sites for
hypoxia-inducible binding proteins in the 3'UTR (Levy et
al., 1996a
,b
, 1997
; Claffey et al., 1998
); however, it
appears that the VEGF 3'UTR is not sufficient to confer hypoxic regulation on a reporter mRNA in vivo (Levy et al., 1997
;
Claffey et al., 1998
), and recapitulation of hypoxic
stabilization of the VEGF mRNA in a reporter system has not been achieved.
Apart from VEGF, the stability of a number of other mRNAs has also been
found to be regulated by hypoxia, including the mRNAs for
erythropoietin, tyrosine hydroxylase, and glut-1 (Goldberg et
al., 1991
; Czyzyk-Krzeska et al., 1994
; Stein et
al., 1995
; McGary et al., 1997
). Although the
mechanistic details of the stabilization of these other mRNAs have yet
to be elucidated, it is also likely that the binding of proteins to
elements within the 3' untranslated regions (3'UTRs) of these mRNAs
will be important in the regulation of mRNA stability (Czyzyk-Krzeska
and Beresh, 1996
; Czyzyk-Krzeska et al., 1997
; McGary
et al., 1997
). VEGF is encoded by a single gene that gives
rise to four isoforms by alternative splicing (Tischer et
al., 1991
; Shima et al., 1996
). Of these four isoforms,
the 164 and 121 amino acid isoforms appear to be the primary mitogenic
forms in vivo (Houck et al., 1991
; Cohen et al.,
1995
). All four isoforms share the same 5' UTR, which is unusually long
and GC-rich (Levy et al., 1995
; Shima et al.,
1996
; Tischer et al., 1991
). The unusual structure of the
5'UTR suggests that elements regulating translation and/or stability of
the mRNA may also reside within this region. As a first step toward
elucidating the molecular mechanisms involved in the regulation of VEGF
mRNA stability, we have systematically analyzed the regions in the VEGF
mRNA that are responsible for its lability under normoxic conditions
and the regions that are responsible for stabilization in response to
hypoxia. We find that multiple regions in the VEGF mRNA cooperate both
to ensure the rapid degradation of the mRNA under normoxic conditions
and to allow stabilization of the mRNA in response to hypoxia.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture and Transfection
Mouse BALB/c3T3 lines were grown in DMEM with 7.5% FCS. Cells
(2 × 106) were transfected with 20 µg of plasmid
(linearized with ScaI) by CaPO4 precipitation,
grown for 24-48 h, and selected in 400 µg/ml G418. After
10-12 d, the resulting colonies (containing at least 100 independent
clones) were pooled and maintained in 200 µg/ml G418 sulfate (Life
Technologies, Gaithersburg, MD). Hypoxic conditions (1%
O2, 5-8% CO2) were generated either by ascorbic acid depletion of atmospheric oxygen in a sealed 2.5-l container (AnaeroGen AN25; Oxoid, Basingstoke, Hampshire,
England) or by infusion of N2 gas using a Reming
Bioinstruments (Redfield, NY) Oxyreducer unit on a standard
CO2 incubator. Actinomycin D was used at 5 µg/ml to
inhibit transcription of endogenous genes. Serum stimulation of cells
was performed essentially as described previously (Lagnado et
al., 1994
), except that 1) hypoxic incubation and serum starvation
were performed concurrently for 24 h and 2) FCS was added directly
to the medium for serum stimulation.
Plasmid Constructions
Plasmids were generated by insertion of murine VEGF sequences
into the pfGH plasmid (see Figure 2). Plasmid pfGH-3'V contains the
entire 3'UTR of VEGF (from the first nucleotide after the VEGF
termination codon to 2.2 kb downstream) and was generated by cloning a
2.2 kb Pfu PCR fragment from p3'VEGF, a clone derived from a
FIX II mouse genomic VEGF clone (Carmeliet et al., 1996
; Breier, unpublished observations), between the KpnI and
SacI sites of pfGH. Plasmid pf164-3'GH substitutes the
coding region for human growth hormone (hGH) with the coding region for
the VEGF 164 amino acid isoform. The plasmid was generated by cloning a XbaI-KpnI fragment from pVEGF1, a cDNA clone of
the VEGF 164 amino acid isoform (Breier et al., 1992
), into
the NheI and KpnI sites of pfGH. Plasmid
pf5'V-GH-3'GH contains the entire VEGF 5'UTR inserted into the 5'UTR of
the fGH reporter gene and was constructed by incorporating a
NcoI site at the VEGF initiation codon by PCR amplification
with Pfu polymerase from pV5NBgl63 (Damert et
al., 1997
) and cloning a HindIII to NcoI
fragment (sequence coordinates 1218 to 2234 [Shima et al.,
1996
]) into the same sites in pfGH. Plasmid pf164-3'V, which contains
the 164 amino acid coding region linked to the VEGF 3'UTR, was created
by cloning a MluI to KpnI fragment from
pf164-3'GH into the same sites in plasmid pfGH-3'V. Plasmid
pf5'V-GH-3'V contains the VEGF 5'UTR linked to the hGH coding region
and VEGF 3'UTR and was constructed by cloning a MluI to
KpnI fragment from pf5'V-GH-3'GH into the same sites in pfGH-3'V. Plasmid pf5'V-164-3'GH contains the VEGF 5'UTR and 164 amino
acid coding region and was created by incorporating a NcoI site at the VEGF initiation codon by PCR amplification with
Pfu polymerase and cloning the NcoI to
KpnI PCR fragment containing the VEGF coding region into the
same sites in pf5'V-GH-3'GH. To create a reconstructed version of the
entire VEGF mRNA, tagged at the coding/3'UTR junction to distinguish it
from the endogenous VEGF mRNA, the MluI to KpnI
fragment from pf5'V-164-3'GH was cloned into the same sites in
pfGH-3'V. The resulting plasmid was termed pfVEGF and contains 48 bp of
pBluescript polylinker between the VEGF termination codon and the start
of the 3'UTR.
Plasmid pGH/VEGF was created by cloning a 389 bp BglII-SmaI fragment from pfGH-3'V into the BamHI and SmaI sites of pBluescriptSK+. This plasmid contains junction sequence between the hGH gene and the VEGF 3'UTR and was used to detect the endogenous VEGF mRNA and also to detect the chimeric fGH-3'V mRNA. pGEM164/3' was created by cloning a 260 bp EcoRI to SmaI fragment from pf164-3'V into the same sites in pGEM4Z. This plasmid contains the 164/3'UTR junction present in the reconstructed fVEGF mRNA and was used to generate probes to allow discrimination between the reconstructed fVEGF mRNA and the endogenous VEGF mRNA.
RNA Isolation and Analysis
Total RNA was isolated either from untransfected BALB/c3T3 cells
or from polyclonal pools of transfected cells by guanidine thiocyanate
extraction (Chomczynski and Sacchi, 1987
). Specific transcripts were
detected either by Northern analysis (Sambrook et al., 1989
)
or by RNase protection analysis (Lagnado et al., 1994
). The
GAPDH1 mRNA and chimeric mRNAs containing the hGH coding
region were detected as described previously (Lagnado et
al., 1994
). For detection of the endogenous VEGF mRNA, a T7
synthesized transcript from pGH/VEGF digested with XbaI was
used. For detection of mRNAs containing the VEGF 164 amino acid coding
region, an SP6 synthesized transcript from plasmid pf164-3'GH digested
with HinfI was used. The reconstructed fVEGF mRNA was
detected by use of a T7 synthesized transcript from plasmid pGEM164/3'
digested with EcoRI. The neomycin phosphotransferase (neo)
mRNA was detected by use of plasmid pGNEO digested with RsaI
and T7 RNA polymerase.
-actin mRNA was detected by use of pS4H
-actin (a subclone of pHF-A1 [Ponte et al., 1983
])
digested with PvuII and SP6 RNA polymerase.
Quantitation and Analysis of Specific mRNAs
The amount of specific mRNA was quantitated by PhosphorImager
(Molecular Dynamics, Sunnyvale, CA) analysis of RNase protection gels. The level of each mRNA was normalized with respect to either GAPDH or neo mRNA, or was plotted without normalization, as indicated in the figure legends. Because the amount of GAPDH mRNA increased linearly during the 8 h after serum stimulation of normoxic cells, when GAPDH was used for normalization a regression line was fitted to
the pooled GAPDH mRNA levels for each experiment and used to calculate
the expected GAPDH level for each sample, as has been described
previously (Lagnado et al., 1994
). Levels of the fGH mRNA
and its variants were then normalized by multiplying the ratio
(expected GAPDH/observed GAPDH). This correction avoided overestimating
the instability of chimeric mRNAs but did not change relative
destabilizing effects. The prestimulation level of GAPDH mRNA was found
to be elevated by hypoxia (Graven et al., 1994
), but the
level of GAPDH mRNA showed no significant change for the period of the
8-h time course after serum stimulation. To demonstrate that the
serum-induced highest mRNA values were similar between experiments and
with each reporter gene, the maximum levels of the reporter mRNA are
given in each figure legend. To allow comparison between experiments
(for which the times of phosphorimage exposure may differ), the maximum
value was expressed relative to the normoxic GAPDH level.
Transcriptional induction and turn-off of the fos promoter
were unaffected by hypoxia.
The half-life of the endogenous VEGF mRNA was calculated using GraphPad (San Diego, CA) Prism (version 1.03) software and fitting the data to an equation for single-phase exponential decay. Apparent half-lives (t1/2) and decay rates (k) determined from serum stimulation data were calculated after subtraction of the background level from the unstimulated sample (t = 0) and fitting the data to an equation for single-phase exponential decay. For independently functioning destabilizing activities, the rate of decay of a mRNA containing more than one destabilizing element (kobs) should be equal to the sum of the individual decay rates (k1, k2, etc.).
| |
RESULTS |
|---|
|
|
|---|
VEGF mRNA Stability Is Regulated by Hypoxia in BALB/c3T3 Fibroblasts
The stability of the VEGF mRNA has been shown to be regulated by
hypoxia in a number of cell lines, although in some tumor-derived cell
lines the VEGF mRNA is constitutively stabilized (White et al., 1995
). We initially chose to use NIH3T3 cells to study the regulation of VEGF mRNA stability, because these cells are not tumor-derived and because we have previously used these cells to
identify mRNA destabilizing elements (Lagnado et al., 1994
; Brown et al., 1996
); however, the VEGF mRNA was only
modestly induced by hypoxia in NIH3T3 cells (Dibbens, unpublished
observations). In contrast, in BALB/c3T3 fibroblasts we found
that the VEGF mRNA was induced ~10-fold by 24 h of hypoxia
(Figure 1A), and we therefore chose this
cell line for subsequent experiments.
|
In BALB/c3T3 cells incubated under normoxic conditions (20%
O2) and treated with actinomycin D to inhibit
transcription, the VEGF mRNA decayed with a half-life of 65 min (Figure
1B). We observed a gradual stabilization of the VEGF mRNA with extended
times of exposure to actinomycin D, a phenomenon that has been observed for a number of other mRNAs (Shaw et al., 1988
; Wisdom and
Lee, 1991
; Zubiaga et al., 1995
). Nevertheless, in cells
incubated under hypoxic conditions (1% O2) for 24 h,
the half-life of the VEGF mRNA was estimated to be 3.7 h,
demonstrating stabilization of the mRNA in response to hypoxia (Figure
1B). The half-life of the VEGF mRNA under normoxia and the degree of
stabilization in response to hypoxia determined in this way were in
good agreement with similar previous studies (Ikeda et al.,
1995
; Stein et al., 1995
; Levy et al., 1996a
,b
).
The VEGF mRNA Contains Destabilizing Elements in the 5'UTR, Coding Region, and 3'UTR
On the basis of the results of a previous in vitro study (Levy
et al., 1996a
,b
), our expectation was that the VEGF 3'UTR
would be sufficient to confer correct regulation of stability on a
reporter mRNA. To investigate the role of the VEGF 3'UTR in regulating mRNA stability, we inserted the entire murine VEGF 3'UTR into the 3'UTR
of the fGH reporter gene, creating the hybrid gene fGH-3'V (Figure
2). This construct was transfected into
BALB/c3T3 cells, and a polyclonal population of G418 resistant cells
was established. Transcription of the normally stable fGH mRNA is
driven from the c-fos promoter, from which a brief pulse of
transcription can be generated by serum stimulation, allowing
subsequent degradation of the mRNA to be monitored (Kabnick and
Housman, 1988
; Shyu et al., 1989
; Lagnado et al.,
1994
). This system allows a direct means of determining the stability
of mRNAs rather than an indirect means, such as changes in the
steady-state levels of reporter enzymes or the use of nonspecific
inhibitors of transcription.
|
Insertion of the VEGF 3'UTR into the reporter gene significantly
destabilized the fGH reporter mRNA under normoxic conditions (Figure
3, A and B), demonstrating the presence
of destabilizing elements in the VEGF 3'UTR; however, the half-life of
the fGH-3'V mRNA under normoxic conditions was ~2 h (Figure 3C),
significantly more stable than the half-life of the endogenous VEGF
mRNA (65 min) determined using actinomycin D, and suggests that
elements outside the 3'UTR may contribute to the lability of the VEGF
mRNA under normoxic conditions.
|
The murine VEGF mRNA comprises an unusually long 5'UTR of 1014 bases
and a coding region of variable size, depending on the particular VEGF
isoform expressed (Shima et al., 1996
). To assess whether
the 5'UTR contributed to the normoxic instability of the VEGF mRNA, we
inserted the entire VEGF 5'UTR into the 5'UTR of the fGH reporter gene,
yielding f5'V-GH-3'GH (Figure 2). The effect of the VEGF coding region
on regulation of mRNA stability was tested by replacing the growth
hormone coding region in the fGH gene with the coding region for the
164 amino acid isoform, yielding f164-3'GH (Figure 2).
The decay of the hybrid mRNAs was measured after serum stimulation of
the c-fos promoter under normoxic conditions. Both the 5'UTR
and the coding region destabilized the reporter mRNA (Figure 4, A and B), demonstrating that each
region contained independently functioning destabilizing elements.
Comparison of the decay profiles (Figures 3C and 4B) indicated that the
3'UTR and coding region destabilized the reporter mRNA to a similar
extent (t1/2 = 2.0 and 1.9 h,
respectively), whereas the 5'UTR was less destabilizing (t1/2 = 2.4 h).
|
We confirmed the destabilizing potential of each of the three regions by determining the relative expression level of each of the mRNAs expressed constitutively from the fos promoter under normoxic conditions (Figure 4C). To account for any differences in transfection efficiencies between plasmids in each of the polyclonal populations, we used the mRNA from the linked neo gene for normalization. Variants of the fGH mRNA containing known destabilizing elements (fGHAU1; fGHSL2) gave reduced levels of the mRNA as expected (Figure 4C), and all three regions of the VEGF mRNA reduced the level of the reporter mRNA (Figure 4C), confirming the presence of destabilizing elements.
We conclude that regions outside the 3'UTR are important for the regulation of VEGF mRNA stability and that the VEGF mRNA contains destabilizing elements not only in the 3'UTR but also in the 5'UTR and coding region.
Multiple Elements Are Required for the Lability of the VEGF mRNA under Normoxic Conditions
The half-lives of the hybrid mRNAs bearing either the 5'UTR,
coding region, or 3'UTR were all significantly greater than that found
for the endogenous VEGF mRNA. This indicated that the lability of the
endogenous mRNA under normoxic conditions may be caused by the combined
action of multiple instability elements. We therefore tested the effect
of each pairwise combination of the 5'UTR, coding region, and 3'UTR on
degradation of the reporter mRNA (Figure 2). Each pairwise combination
was more unstable than each of the contributing single regions (Figure
5). The rate of decay (k) for
each of the pairwise combinations (Figure 5) was approximately the sum
of the decay rates for each individual region (Figures 3 and 4),
indicating that each region acts independently to destabilize the
reporter mRNA. This additivity also suggests that each destabilizing activity acts to promote a common, rate-limiting step in the overall degradation pathway of the VEGF mRNA. The half-life of each combination was similar to that of the endogenous VEGF mRNA, indicating that any
two of the three regions suffices to recapitulate the lability of the
mRNA. We conclude that the VEGF mRNA contains multiple, independently
functional destabilizing elements and that the rapid degradation of the
VEGF mRNA under normoxia is due to the combined action of these
elements.
|
The VEGF 5'UTR, Coding Region, or 3'UTR Do Not Independently Confer Hypoxic Stabilization
Having found that each of the three regions in the VEGF mRNA can
independently destabilize a reporter mRNA, we tested whether each of
the regions responds to hypoxia; however, maintaining the cells in a
hypoxic environment did not result in any significant stabilization of
any of the hybrid mRNAs (Figure 6A). To
verify that the cells had been adequately exposed to hypoxia, we
measured the levels of the mRNA from the endogenous VEGF gene. We found that the endogenous VEGF mRNA was induced approximately sevenfold by
hypoxia and remained constant throughout the 8-h time course after
serum stimulation (Figure 6B), indicating that the cells were
responding appropriately to hypoxia and that serum stimulation was
unlikely to affect mRNAs already stabilized in response to hypoxia.
|
The inability of the 5'UTR, coding region, and 3'UTR to independently confer hypoxic stabilization on the reporter mRNA indicated that multiple elements are required for stabilization and that the determinants for stabilization are distinct from those that act to destabilize the mRNA under normoxic conditions.
Hypoxic Stabilization of the VEGF mRNA Requires the Cooperation of RNA Elements from Multiple Regions of the mRNA
The inability of the 5'UTR, coding region, or 3'UTR to confer
hypoxic stabilization suggested that stabilization may require the
participation of two or more regions in the VEGF mRNA. We therefore
tested the ability of each of the pairwise combinations of the 5'UTR,
coding region, and 3'UTR to be stabilized in response to hypoxia.
Although combining regions resulted in enhanced degradation rates in
normoxic cells, there was no stabilization in response to hypoxia
(Figure 7). Because the level of GAPDH
mRNA, which is used as an internal standard, is increased as a result
of hypoxia, we present the data with and without normalization, to show
that there is no apparent bias of the decay rate as a result of the normalization procedure.
|
Because there was no regulation of stability with the
pairwise combinations, we combined all three regions, essentially
regenerating the entire VEGF mRNA, but with a 48-base sequence tag
inserted between the coding region and the 3'UTR. This allowed the
discrimination between the reconstructed mRNA, termed fVEGF (Figure 2),
and the endogenous VEGF mRNA. In contrast to the results obtained with the pairwise combinations, we found that the reconstructed fVEGF mRNA
was stabilized in response to hypoxia (Figure
8, A and B). Again, the
data are shown with and without normalization, to show that
normalization with GAPDH did not significantly alter the rate of decay
of the fVEGF mRNA. We observed stabilization of the reconstructed fVEGF
mRNA in each of three repetitions of the experiment, including
experiments performed simultaneously with pairwise combinations that
showed no hypoxic stabilization (Figure 7). The half-life of the
reconstructed mRNA was 65 min under normoxic conditions, and the mRNA
was stabilized 2.9-fold in response to hypoxia (Figure 8C), essentially
recapitulating the stabilization found with the endogenous VEGF mRNA
(Figure 1). The stabilization of the reconstructed fVEGF mRNA, but not
any of the pairwise combinations, demonstrates that hypoxic
stabilization of the VEGF mRNA requires the cooperation of elements in
all three regions of the mRNA.
|
The endogenous VEGF mRNA also showed a pattern of serum stimulation and decay under normoxic conditions (Figure 8D), suggesting that the VEGF promoter is subject to a pulse of transcription in response to serum stimulation. The apparent half-life of the endogenous mRNA under these conditions was ~100 min. Under hypoxia, the kinetics of VEGF expression were consistent with stabilization of the mRNA, with an apparent half-life of 210 min (Figure 8D).
We conclude that the VEGF mRNA contains multiple, independently functional destabilizing elements, and the cooperation of RNA elements from three different regions is essential for stabilization of the mRNA in response to hypoxia.
| |
DISCUSSION |
|---|
|
|
|---|
The regulation of VEGF mRNA stability is of particular interest,
not only because VEGF is a member of the class of hypoxia-stabilized mRNAs, but also because of its importance as a potential target for
antiangiogenic therapy (Kim et al., 1993
; Millauer et
al., 1994
). The design of agents to inhibit or promote the
activity of VEGF requires elucidation of the specific mechanisms
controlling its expression. For this reason there is considerable
interest in identifying the determinants in the VEGF mRNA involved in
its lability under normoxic conditions and its stabilization in
response to hypoxia.
In this study we investigated the role of various regions in the VEGF
mRNA in regulating its lability in vivo. The use of a reporter mRNA
driven from the fos promoter allowed us to determine the
effect of different regions of the VEGF mRNA on the stability of a
reporter gene, rather than using indirect means such as changes in the
steady-state levels of reporter enzymes or the use of nonspecific inhibitors of transcription. In all of our constructs we maintained the
positional and translational context of the inserted region in the
reporter mRNA. We found that the VEGF mRNA contains multiple, independently functional destabilizing elements and that the rapid degradation of the VEGF mRNA under normoxia is due to the combined action of these elements. The normoxic half-life of the entire reconstructed mRNA was not significantly different from those calculated for each pairwise combination of the three regions, suggesting that any two of the three regions suffices to recapitulate the lability of the mRNA; however, this finding could reflect the fact
that the fos promoter, which produces a transcriptional pulse of ~30 min duration (Rivera et al., 1990
), cannot
resolve half-lives significantly <1 h.
A number of other mRNAs have been shown to contain destabilizing
elements in both the 3'UTR and coding region, including the fos and myc mRNAs (Kabnick and Housman, 1988
;
Shyu et al., 1989
; Wisdom and Lee, 1991
; Herrick and Ross,
1994
); however, the ability of the VEGF 5'UTR to destabilize the
reporter mRNA in our studies suggests that a destabilizing element is
also present in the 5'UTR. The presence of a destabilizing element in
the 5'UTR is highly unusual, although we note that the first 40 bases
of the fos mRNA are able to weakly destabilize a globin
reporter mRNA (Kabnick and Housman, 1988
). We found that the VEGF
5'UTR, coding region, and 3'UTR were also potently destabilizing in
NIH3T3 cells, indicating that the destabilizing activity of each region
was not restricted to the BALB/c3T3 cells used in our study. Although
the mechanism of destabilization promoted by each of the destabilizing
elements in the VEGF mRNA remains to be determined, the existence of
multiple destabilizing elements in the VEGF mRNA indicates that
multiple degradation pathways have evolved to ensure rapid turnover of the mRNA under normoxic conditions; however, it has also become apparent that a number of tumor-derived cell lines constitutively express elevated levels of VEGF caused by persistent stabilization of
the mRNA (White et al., 1995
; Iliopoulos et al.,
1996
; Levy et al., 1996a
,b
). The existence of multiple
instability elements in the VEGF mRNA and the ability of any two of the
three regions to recapitulate the lability of the mRNA suggests that
the persistent stabilization of the VEGF mRNA in these tumor-derived
cells may be due to the constitutive activation of a stabilizing
pathway rather than the loss of function of two distinct degradation pathways.
In contrast to the additive effects of individual regions in
destabilizing the mRNA, we found that hypoxic stabilization of the VEGF
mRNA occurs only if the 5'UTR, coding region, and 3'UTR are all present
in the mRNA. Based on the results of a previous study in which
hypoxic stabilization of the VEGF 3'UTR was observed in a cell-free
extract system (Levy et al., 1996a
,b
), our expectation was
that the 3'UTR would be sufficient to confer correct regulation on a
reporter mRNA in vivo; however, our observation in intact cells
demonstrates that the regulation of VEGF mRNA stability is more complex
than previous studies have suggested and involves considerable
complexity in the molecular interactions. This could be due to the
requirement for three distinct RNA binding proteins each interacting
with a discrete element, or it could reflect the need to form a
particular RNA structure from various RNA sequences that is recognized
by a single protein.
The ability to recapitulate hypoxic stabilization is significant for a number of reasons. It will allow further delineation of the elements required for stabilization and therefore provide a route to the isolation of factors involved in stabilization of the mRNA. It also provides the ability to study the effect of various conditions or factors on mRNA stability directly, without the complication of associated changes in transcription from the VEGF promoter. Furthermore, our demonstration of the need for the cooperation of multiple elements for hypoxic stabilization of the VEGF mRNA could have important implications for antiangiogenic therapy. Inhibition of the function of any of the cooperating elements should prevent accumulation of the mRNA in response to hypoxia.
Although the VEGF 3'UTR is not sufficient to confer hypoxic
stabilization, our results show that elements in the 3'UTR are essential for stabilization. This is supported by other studies that
show that RNA elements in the 3'UTR play a role in hypoxic stabilization. Antisense expression of HuR, a protein that binds to a
distal AU-rich region in the VEGF 3'UTR, prevents hypoxic stabilization
of the VEGF mRNA (Levy et al., 1998
). HuR is a member of the
Elav-like family of binding proteins and has been implicated in the
function of AU-destabilizing elements (Myer et al., 1997
). Additionally, one of the hypoxia-inducible proteins found to bind to a
pyrimidine-rich element in the VEGF 3'UTR in vitro also binds to a
similar element found in the erythropoietin and tyrosine hydroxylase
mRNAs (Czyzyk-Krzeska and Beresh, 1996
; Iliopoulos et al.,
1996
; Levy et al., 1996a
,b
; McGary et al., 1997
).
Mutation of this element in the erythropoietin mRNA destabilizes the
mRNA in vivo under normoxic conditions and prevents hypoxic
stabilization of the mRNA (McGary et al., 1997
).
We found that the endogenous VEGF mRNA showed a pattern of serum
stimulation and decay under normoxic conditions, indicating that the
VEGF promoter is also subject to a pulse of transcription in response
to serum stimulation (Figure 8). A similar pattern of VEGF
transcription in response to serum has also been seen in human
fibroblasts (Enholm et al., 1997
). The pattern of decay of
the endogenous mRNA under hypoxia was consistent with stabilization of
the mRNA, although nuclear run-on experiments are required to verify
that the shut-off of transcription under hypoxia and normoxia occurs at
the same rate. Nevertheless, the degree of hypoxic stabilization
(twofold) of the endogenous mRNA determined from these apparent
half-lives was similar to that determined from the reconstructed mRNA.
If the pulse of transcription generated from the VEGF promoter in
response to serum stimulation is similar under normoxia and hypoxia,
this method may allow the direct determination of the effect of various
agents on stabilization of the endogenous VEGF mRNA.
The degree of complexity of the molecular interactions required for the
regulation of stability of some mRNAs is only now becoming apparent.
Our finding that multiple regions are required for VEGF mRNA
stabilization parallels similar findings with the interleukin (IL)-2
and IL-11 mRNAs. Stabilization of the IL-2 mRNA in T cells by the c-Jun
amino-terminal kinase (JNK) pathway requires elements at the junction
of the 5'UTR and coding region as well as elements in the 3'UTR (Chen
et al., 1998
), and stabilization of the IL-11 mRNA in bone
marrow stromal cells in response to phorbol ester requires all three
regions of the mRNA (Yang et al., 1996
); however, the VEGF
mRNA appears to be unique in the complexity of the interactions
required for both its lability and stabilization. Such complexity most
likely reflects the need for expression of the molecule to be very
tightly regulated and is most apparent in the failure in vascular
development in mice carrying a single defective VEGF gene (Carmeliet
et al., 1996
; Ferrara et al., 1996
). This
heterozygous lethality is unprecedented in an autosomal gene and
indicates that the level of VEGF is critical for correct embryonic
vascular development. The ability to regulate the stability of
the VEGF mRNA allows a level of control in addition to regulation of
transcription, and this may be important for coordinating expression of
VEGF with the many other factors that also play a role in the
angiogenic process (Folkman and Shing, 1992
).
| |
ACKNOWLEDGMENTS |
|---|
We thank T. Gonda for critical reading of this manuscript. This work was supported by grants from the AntiCancer Foundation of South Australia and the Kathleen Cunningham Foundation. Initial postdoctoral support for J.A.D. was provided by an F.T.T. Fricker Fellowship from the Department of Medicine, University of Adelaide.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
greg.GOODALL{at}imvs.sa.gov.au.
Dedicated to the memory of Werner Risau (December 18, 1953-December 13, 1998).
| |
ABBREVIATIONS |
|---|
Abbreviations used: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; neo, neomycin phosphotransferase; RNase, ribonuclease; UTR, untranslated region; VEGF, vascular endothelial growth factor.
| |
REFERENCES |
|---|
|
|
|---|
-globin mRNAs are located at several sites in each mRNA.
Mol. Cell. Biol.
8, 3244-3250
-skeletal and
-cardiac actin but multicopy for
- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution.
Mol. Cell. Biol.
3, 1783-1791This article has been cited by other articles:
![]() |
X. Zhang, T. Zou, J. N. Rao, L. Liu, L. Xiao, P.-Y. Wang, Y.-H. Cui, M. Gorospe, and J.-Y. Wang Stabilization of XIAP mRNA through the RNA binding protein HuR regulated by cellular polyamines Nucleic Acids Res., December 1, 2009; 37(22): 7623 - 7637. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. TAHARA, T. ARISAWA, T. SHIBATA, M. NAKAMURA, H. YAMASHITA, D. YOSHIOKA, M. OKUBO, N. MARUYAMA, T. KAMANO, Y. KAMIYA, et al. Effect of Polymorphisms in the 3'-Untranslated Region (3'-UTR) of VEGF Gene on Gastric Pre-malignant Condition Anticancer Res, February 1, 2009; 29(2): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Zwetsloot, L. M. Westerkamp, B. F. Holmes, and T. P. Gavin AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise J. Physiol., December 15, 2008; 586(24): 6021 - 6035. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, L. Zhang, Q. Wu, and D. D. Boyd Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin {beta}4 and Vascular Endothelial Growth Factor as Downstream Targets J. Biol. Chem., December 12, 2008; 283(50): 35295 - 35304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bastide, Z. Karaa, S. Bornes, C. Hieblot, E. Lacazette, H. Prats, and C. Touriol An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform Nucleic Acids Res., April 1, 2008; 36(7): 2434 - 2445. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vumbaca, K. N. Phoenix, D. Rodriguez-Pinto, D. K. Han, and K. P. Claffey Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis Mol. Cell. Biol., January 15, 2008; 28(2): 772 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Essop Cardiac metabolic adaptations in response to chronic hypoxia J. Physiol., November 1, 2007; 584(3): 715 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification Journal of Dental Research, October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sandler Bevacizumab in Non Small Cell Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4613s - 4616s. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, H. Harada, and A. Taniguchi The Exon 6ABC Region of Amelogenin mRNA Contribute to Increased Levels of Amelogenin mRNA through Amelogenin Protein-enhanced mRNA Stabilization J. Biol. Chem., October 27, 2006; 281(43): 32439 - 32444. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakurai, S. Maeda, L. Chang, and M. Karin Inaugural Article: Loss of hepatic NF-{kappa}B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation PNAS, July 11, 2006; 103(28): 10544 - 10551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, C. L. Cetrulo, and T. C. Theoharides Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., March 1, 2006; 69(3): 998 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Garton, A. P.A. Crew, M. Franklin, A. R. Cooke, G. M. Wynne, L. Castaldo, J. Kahler, S. L. Winski, A. Franks, E. N. Brown, et al. OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models Cancer Res., January 15, 2006; 66(2): 1015 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-N. Zhao, W. Gu, N. X. Fang, N. A. Saunders, and I. H. Frazer Gene Codon Composition Determines Differentiation-Dependent Expression of a Viral Capsid Gene in Keratinocytes In Vitro and In Vivo Mol. Cell. Biol., October 1, 2005; 25(19): 8643 - 8655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Harvey, K.L. Kind, M. Pantaleon, D.T. Armstrong, and J.G. Thompson Oxygen-Regulated Gene Expression in Bovine Blastocysts Biol Reprod, October 1, 2004; 71(4): 1108 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Marano, M. Brankov, and P. E. Rakoczy Discovery of a Novel Control Element within the 5'-Untranslated Region of the Vascular Endothelial Growth Factor: REGULATION OF EXPRESSION USING SENSE OLIGONUCLEOTIDES J. Biol. Chem., September 3, 2004; 279(36): 37808 - 37814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Roybal, S. Yang, C.-W. Sun, D. Hurtado, D. L. Vander Jagt, T. M. Townes, and S. F. Abcouwer Homocysteine Increases the Expression of Vascular Endothelial Growth Factor by a Mechanism Involving Endoplasmic Reticulum Stress and Transcription Factor ATF4 J. Biol. Chem., April 9, 2004; 279(15): 14844 - 14852. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Mawji, G. B. Robb, S. C. Tai, and P. A. Marsden Role of the 3'-Untranslated Region of Human Endothelin-1 in Vascular Endothelial Cells: CONTRIBUTION TO TRANSCRIPT LABILITY AND THE CELLULAR HEAT SHOCK RESPONSE J. Biol. Chem., March 5, 2004; 279(10): 8655 - 8667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramanathan, A. Giladi, and S. J. Leibovich Regulation of Vascular Endothelial Growth Factor Gene Expression in Murine Macrophages by Nitric Oxide and Hypoxia Exp Biol Med, June 1, 2003; 228(6): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duan, M. S. Wainwright, J. M. Comeron, N. Saitou, A. R. Sanders, J. Gelernter, and P. V. Gejman Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor Hum. Mol. Genet., February 1, 2003; 12(3): 205 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Coles, P. Diamond, L. Lambrusco, J. Hunter, J. Burrows, M. A. Vadas, and G. J. Goodall A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts Nucleic Acids Res., November 15, 2002; 30(22): 4845 - 4854. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, R. Chester, J. A. Jackson, S. J. Boffey, P. J. Valentine, J. O. Curwen, H. L. Musgrove, et al. ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration Cancer Res., August 15, 2002; 62(16): 4645 - 4655. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Abcouwer, P. L. Marjon, R. K. Loper, and D. L. Vander Jagt Response of VEGF Expression to Amino Acid Deprivation and Inducers of Endoplasmic Reticulum Stress Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2791 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chinn, D. Ciais, S. Bailly, E. Chambaz, J. LaMarre, and J.-J. Feige Identification of Two Novel ACTH-Responsive Genes Encoding Manganese-Dependent Superoxide Dismutase (SOD2) and the Zinc Finger Protein TIS11b [Tetradecanoyl Phorbol Acetate (TPA)-Inducible Sequence 11b] Mol. Endocrinol., June 1, 2002; 16(6): 1417 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
S R Boyd, D S W Tan, L de Souza, M H Neale, N E Myatt, R A Alexander, M Robb, J L Hungerford, and I A Cree Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth Br J Ophthalmol, April 1, 2002; 86(4): 440 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Collier, D. Oberg, X. Zhao, and S. Schwartz Specific Inactivation of Inhibitory Sequences in the 5' End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial Cells J. Virol., March 15, 2002; 76(6): 2739 - 2752. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Putland, T. A. Sassinis, J. S. Harvey, P. Diamond, L. S. Coles, C. Y. Brown, and G. J. Goodall RNA Destabilization by the Granulocyte Colony-Stimulating Factor Stem-Loop Destabilizing Element Involves a Single Stem-Loop That Promotes Deadenylation Mol. Cell. Biol., March 15, 2002; 22(6): 1664 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blancher, J. W. Moore, N. Robertson, and A. L. Harris Effects of ras and von Hippel-Lindau (VHL) Gene Mutations on Hypoxia-inducible Factor (HIF)-1{alpha}, HIF-2{alpha}, and Vascular Endothelial Growth Factor Expression and Their Regulation by the Phosphatidylinositol 3'-Kinase/Akt Signaling Pathway Cancer Res., October 1, 2001; 61(19): 7349 - 7355. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M. Siafakas, M. Jordan, H. Wagner, E.C. Breen, H. Benoit, and P.D. Wagner Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Eur. Respir. J., April 1, 2001; 17(4): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Robinson and S. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci., January 3, 2001; 114(5): 853 - 865. [Abstract] [PDF] |
||||
![]() |
M. Garayoa, A. Martínez, S. Lee, R. Pío, W. G. An, L. Neckers, J. Trepel, L. M. Montuenga, H. Ryan, R. Johnson, et al. Hypoxia-Inducible Factor-1 (HIF-1) Up-Regulates Adrenomedullin Expression in Human Tumor Cell Lines during Oxygen Deprivation: A Possible Promotion Mechanism of Carcinogenesis Mol. Endocrinol., June 1, 2000; 14(6): 848 - 862. [Abstract] [Full Text] |
||||
![]() |
R. Miraliakbari, N. A. Francalancia, R. M. Lust, J. A. Gerardo, P. C. Ng, Y. S. Sun, and W. R. Chitwood Jr Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia Ann. Thorac. Surg., June 1, 2000; 69(6): 1750 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Chen, R. Gherzi, J. S. Andersen, G. Gaietta, K. Jürchott, H.-D. Royer, M. Mann, and M. Karin Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation Genes & Dev., May 15, 2000; 14(10): 1236 - 1248. [Abstract] [Full Text] |
||||
![]() |
E. Vassella, J. V. Den Abbeele, P. Bütikofer, C. K. Renggli, A. Furger, R. Brun, and I. Roditi A major surface glycoprotein of Trypanosoma brucei is expressed transiently during development and can be regulated post-transcriptionally by glycerol or hypoxia Genes & Dev., March 1, 2000; 14(5): 615 - 626. [Abstract] [Full Text] |
||||
![]() |
S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, J. O. Curwen, L. F. Hennequin, A. P. Thomas, E. S. E. Stokes, B. Curry, G. H. P. Richmond, et al. ZD4190: An Orally Active Inhibitor of Vascular Endothelial Growth Factor Signaling with Broad-Spectrum Antitumor Efficacy Cancer Res., February 1, 2000; 60(4): 970 - 975. [Abstract] [Full Text] |
||||
![]() |
L Miquerol, B. Langille, and A Nagy Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression Development, January 9, 2000; 127(18): 3941 - 3946. [Abstract] [PDF] |
||||
![]() |
J. Rak, Y. Mitsuhashi, C. Sheehan, A. Tamir, A. Viloria-Petit, J. Filmus, S. J. Mansour, N. G. Ahn, and R. S. Kerbel Oncogenes and Tumor Angiogenesis: Differential Modes of Vascular Endothelial Growth Factor Up-Regulation in ras-transformed Epithelial Cells and Fibroblasts Cancer Res., January 1, 2000; 60(2): 490 - 498. [Abstract] [Full Text] |
||||
![]() |
G. Pages, E. Berra, J. Milanini, A. P. Levy, and J. Pouyssegur Stress-activated Protein Kinases (JNK and p38/HOG) Are Essential for Vascular Endothelial Growth Factor mRNA Stability J. Biol. Chem., August 18, 2000; 275(34): 26484 - 26491. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hew, C. Lau, Z. Grzelczak, and F. W. Keeley Identification of a GA-rich Sequence as a Protein-binding Site in the 3'-Untranslated Region of Chicken Elastin mRNA with a Potential Role in the Developmental Regulation of Elastin mRNA Stability J. Biol. Chem., August 4, 2000; 275(32): 24857 - 24864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tierney and R. L. Medcalf Plasminogen Activator Inhibitor Type 2 Contains mRNA Instability Elements within Exon 4 of the Coding Region. SEQUENCE HOMOLOGY TO CODING REGION INSTABILITY DETERMINANTS IN OTHER mRNAs J. Biol. Chem., April 20, 2001; 276(17): 13675 - 13684. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Davis, J. M. Monnier, and H. S. Nick A Coding Region Determinant of Instability Regulates Levels of Manganese Superoxide Dismutase mRNA J. Biol. Chem., September 28, 2001; 276(40): 37317 - 37326. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||